Observational study of Fournier's Gangrene and usefulness of Fournier's Gangrene severity index in predicting the outcome by Naveen, P
1 
 
OBSERVATIONAL STUDY OF FOURNIER’S GANGRENE 
AND   USEFULNESS OF FOURNIER’S GANGRENE 
SEVERITY INDEX IN PREDICTING THE OUTCOME  
 
A DISSERTATION SUBMITTED TO 
 
THE TAMILNADU DR.M.G.R MEDICAL UNIVERSITY 
 
In partial fulfilment of the regulations for the award of the  
 
Degree of M.S., (GENERAL SURGERY) 
BRANCH – I 
 
APRIL 2013 
 
 
 
DEPARTMENT OF GENERAL SURGERY 
 
STANLEY MEDICAL COLLEGE AND HOSPITAL 
 
THE TAMILNADU DR.M.G.R MEDICAL UNIVERSITY 
CHENNAI 
  
2 
 
CERTIFICATE 
 
This  is  to  certify  that  the  dissertation  entitled “Observational study 
of Fournier’s Gangrene and Usefulness of Fournier’s Gangrene severity 
index  in predicting the outcome ” is  the  bonafide   work   done  by  Dr. 
P.NAVEEN.,   Post  Graduate student  (2010 – 2013)  in  the  Department   of   
General  Surgery, Government Stanley  Medical College and Hospital, 
Chennai  under  my  direct  guidance  and  supervision, in  partial fulfilment of  
the  regulations of  The  Tamil Nadu Dr. M.G.R  Medical University, Chennai  
for the award of  M.S., Degree (General Surgery) Branch - I, Examination  to  
be held in April 2013. 
 
 
Prof. A. RAJENDRAN, M.S.,                     Prof. P. DARWIN M.S. 
Professor of Surgery,                              Professor and Head of surgery,  
Dept. of General Surgery,                               Dept. of General Surgery,  
Stanley Medical College,                                Stanley Medical College, 
Chennai-600001.                                            Chennai-600001.                                                         
 
 
 
 
PROF. S. GEETHA LAKSHMI, M.D., PhD, 
The Dean, 
Stanley Medical College, 
Chennai-600001. 
3 
 
DECLARATION 
 
I, solemnly declare that this dissertation titled “Observational study of 
Fournier’s Gangrene and Usefulness of Fournier’s Gangrene severity 
index in predicting the outcome” is a bonafide work done by me in the 
Department of General Surgery, Government Stanley Medical College and 
Hospital, Chennai under the guidance and supervision of my unit chief Prof. 
A. RAJENDRAN, M.S., and my Head of the Department Prof. P. DARWIN, 
M.S., 
This dissertation is submitted to The Tamilnadu Dr. M.G.R.  Medical 
University, Chennai in partial fulfilment of the university regulations for the 
award of M.S., Degree (General Surgery) Branch - I, Examination to be held 
in April 2013. 
 
 
 
 
 
Place : Chennai 
 
Date :    December 2013        DR. P.NAVEEN 
 
 
  
4 
 
ACKNOWLEDGEMENT 
I am highly indebted to my guide Prof. A. Rajendran, Professor of 
Surgery for his constant help, inspiration and valuable advice in preparing this 
dissertation. 
I express my deepest sense of gratitude to my Assistant Professors Dr. 
P. Balaji, Dr. G. V. Manoharan for their guidance, teachings and their 
constant motivation . I also thank Dr. G. Venkatesh and Dr. Vignesh for their 
valuable inputs without which this dissertation could not have been completed. 
I consider it a privilege to have done this study under the supervision of 
my beloved Professor and Head of the Department Prof. Darwin, who has 
been a source of constant inspiration and encouragement to accomplish this 
work.  
I express my sincere gratitude to my mentor Prof. S Deivanayagam, 
former Head of Department of General Surgery. I thank him for the constant 
support, able guidance, inspiring words and valuable help he rendered to me 
during my course.  
I am grateful to the Dean Prof. S. Geethalakshmi for permitting to 
conduct the study and use the resources of the College. 
5 
 
It is my earnest duty to thank my parents without whom accomplishing 
this task would have been impossible. 
I am extremely thankful to my patients who consented and participated 
to make this study possible. 
  
6 
 
CONTENTS 
S. no. Chapter Page nos. 
1. Introduction 1 
2. Aims and Objectives 3 
3. Materials & Methods 4 
4. Review of Literature 8 
5. Observation and Results 62 
6. Discussion 76 
7. Conclusions 85 
8. References  
9. 
Annexure 
(i) Proforma 
(ii) Institutional Ethical 
Committee             approval 
Certificate  
(iii) Consent form 
(iv)  Patient information form 
(v) Master chart 
(vi) Turnitin Plagiarism Webtool 
Snapshot 
 
 
7 
 
 
INTRODUCTION 
Fournier’s gangrene (FG) is an acute, rapidly progressive and potentially 
fatal, necrotizing fasciitis of infective etiology affecting the scrotum and penis, 
perineal and perianal regions. It leads to the thrombotic occlusion of small 
subcutaneous vessels, resulting in the development of gangrene of the 
overlying skin. It may extend to the medial aspects of thigh and Anterior 
abdominal wall and can go onto chest wall. 
Bauriene (1)    first reported this form of disease, King Herod the Great of 
Judaea was found to be affected by the disease and he was probably a diabetic.  
.  He described it as a rapidly progressive necrosis of male external genitalia of 
idiopathic nature. The genuine   and more detailed account of this condition 
came from a dermatologist in France Dr. Jean A. Fournier in 1883. 
The disease affects all groups of age and there are many etiological and 
predisposing factors described, this is more common in patients with 
immunosuppressive disorder like diabetes mellitus, malignancy and chronic 
alcoholism. 
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The basic treatment involves active resuscitation, immediate excision of 
all gangrenous and necrotic tissues, to limit the spread of infection, antibiotics 
administration and reconstruction at a later date to achieve skin cover.  
Underlying co-morbidities and the rapid spread of infection contribute to 
the mortality in this condition which ranges from 16-50% in many series in 
spite of the availability of modern critical care units and advanced ICUs. 
Laor et al. developed the Fourniere’s Gangrene Severity Index 
(FGSI) to stratify risk in these patients. FGSI is a numerical score obtained 
from a combination of physiological hospital admission parameters that 
include heart rate, respiratory rate, temperature, serum sodium in meq/l, 
serum potassium in meq/l, creatinine, white cell count, hematocrit and 
serum bicarbonate. Laor proposed that an FGSI above nine is both sensitive 
and specific as a mortality predictor in FG patients. 
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AIM & OBJECTIVES 
1.  To study the incidence and prevalence of Fournier’s gangrene. 
2.  To assess predisposing factors, etiological factors and duration of 
symptoms of Fournier’s gangrene. 
3.  To analyze the need for repeated surgical debridement and the interval 
between them will be recorded and assessed.  
4.       To assess the various factors influencing the final outcome. 
4.  To ascertain the usefulness of Fournier’s gangrene severity index in 
predicting the mortality and morbidity. 
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MATERIALS AND METHODS 
STUDY DESIGN 
Observational study 
SAMPLE SIZE 
35 cases of Fournier’s gangrene 
POPULATION  
Surgical wards at Govt. Stanley Hospital 
PERIOD OF STUDY 
01.01.2012 TO 31.12.2012 
INCLUSION CRITERIA: 
All patients diagnosed to have Fournier’s gangrene between the ages 20 
to 80. 
Both sexes are included. 
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EXCLUSION CRITERIA 
Age < 20 years  
Patients in whom, the initial wound debridement is done in other 
institutions and referred here later. 
METHODS 
1. Patients of Fournier’s gangrene admitted to Emergency surgical ward 
were included in the study after obtaining informed consent. Data’s of 
those patients were drawn and analyzed statistically. 
The following data were collected using proforma 
Detailed history regarding   
o onset 
o Duration of symptoms  
o Progress of  disease 
o Predisposing factors  
o Etiological factors   
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General condition of the patient 
Vital parameters 
• Heart rate 
• Respiratory rate  
• Temperature  
Basic Investigations  
• Complete blood count  
• Sugar, urea, creatinine 
• Serum sodium, potassium and bicarbonate. 
Wound culture & sensitivity 
Based on hospital admission parameters Fournier’s gangrene severity 
index score is calculated and score was obtained to each patient. 
3.  All patients were treated routinely by immediate surgical debridement 
and administration of broad spectrum antibiotics. This was changed once 
the antibiogram report is obtained from sample sent for wound culture 
and sensitivity.  
4.  All patients were followed up during the hospital stay and details 
regarding no. of debridements were noted. 
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5.  The need for diversion procedure to eliminate fecal and urinary 
contamination in extensive wounds is observed and analyzed. 
6.  Once the infection is controlled the method adopted in reconstruction of 
the wound is noted. 
7.  The final outcome of the patient is compared with the clinical score and 
its usefulness in detecting the morbidity and mortality will be analyzed. 
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REVIEW OF LITERATURE 
Fournier’s gangrene is a rather uncommon, aggressively spreading 
infection that initially affects the genitalia and perianal regions with 
progression to the abdomen and thoracic wall. The hall mark of the disease is 
gangrene of skin and subcutaneous tissues due to thrombotic occlusion of 
subcutaneous vessels caused by necrotizing fasciitis. 
HISTORICAL BACKGROUND 
Hippocrates and other medical forefathers had described this scrotal 
condition in their writings, surprisingly; this disease has not been recorded 
until the later part of 1700 s. 
The first report of gangrene of the penis was made in 1764 by 
Baurienne. Baurienne originally described an idiopathic, rapidly progressive 
soft-tissue necrotizing process that led to gangrene of the male genitalia.  
The gangrene process in genitalia was again described in 1873 by 
Avicennaa Ibn sinha in his book “The Canon Of Medicine” 
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The authentic description of the disease was done  by J.A.Fournier in 
1883, specifically in the scrotum. He described it as “fulminant gangrene of 
the penis and scrotum” based on the findings in five young men with 
gangrene of the scrotum (2). 
 The disease was defined with following features: 
(1)  Sudden onset in a hitherto healthy young man,  
(2)  Rapid progression to gangrene and  
(3)  Absence of a definite cause.  
Jean A. Fournier 
Frank Lamot Meleney (from New York), while in Beijing, China during 
World War I (1920s) observed a series of cases with extensive skin and 
subcutaneous tissue necrosis involving extensive areas in the body and found it 
to be causally associated with streptococcus and termed it "streptococcal 
gangrene"(3) and the term “necrotizing fasciitis” was coined by Wilson in the 
year 1952(4). Fournier’s gangrene is otherwise also known as phagedena, 
periurethral phlegmon and synergistic necrotizing cellulitis(5,6,7). 
In the early nineties Sensational medical journalists dramatized the 
whole process of necrotizing fascitis by associating it with flesh-eating bacteria 
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and  authors suggested that the whole process of necrotizing fasciitis to be due 
to bacteria s eating away the tissues and termed it as flesh eating bacteria. 
However it was found to be a misnomer because bacteria only causes 
occlusion of vessels and this in turn results in sloughing of tissues.  
A comprehensive and widely accepted definition of Fournier's gangrene 
was proposed by Smith et al(8)   as 'an infective necrotizing fasciitis of the 
perineal, genital or perianal regions'.This definition was not restricted to 
men of all ages like in Fournier’s original report, but also included women and 
children. 
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RELEVANT ANATOMY 
A thorough knowledge of anatomy of perineum , layers of scrotum and 
penis ,and layers of anterior abdominal wall is required to understand the 
spread of disease. The spread of Fournier’s gangrene is due to the multiple 
intercommunicating fasciae from the region of perineum to anterior abdomen 
wall. Infective and necrotic process involves the superficial and deep fascia 
and the muscles underneath are usually spared. Both debridement initially as 
well as reconstruction later on are affected by this pattern of spread. 
ABDOMEN- SUPERFICIAL LAYERS (SKIN, SUBCUTANEOUS FAT 
AND FASCIA) 
Since this condition is basically the result of infection of the superficial 
and deep fascia, it is absolutely necessary to understand the anatomy and 
relationship of the skin and subcutaneous tissue of the abdominal wall and 
perineum. 
The skin above the inguinal ligament is supported by superficial Camper 
fascia. This is a layer containing fat of variable thickness and superficial 
vessels that supply the skin .Scarpas fascia is deep to camper fascia and this 
continues below as colles fascia in perineum and dartos fascia in scrotum 
(Figure 1). 
 Figure 1
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In the anatomic (upright or erect) position, the perineum is a narrow area 
of soft parts located between the musculature of the gluteal and thigh areas. 
With abduction of the thighs, the perineum has a diamond-shaped 
configuration. The diamond is bordered by the ischiopubic rami and pubic 
symphysis in its anterior half, and in its posterior half, or anal triangle, 
boundaries are provided by the inferior border of the gluteus maximus muscle, 
the ischial tuberosities, the sacrotuberous ligaments, and the coccyx. 
An imaginary line connecting the ischial tuberosities subdivides the 
perineal diamond into two triangles (Figure2) 
ANTERIOR (URO GENITAL TRIANGLE) 
POSTERIOR (ANAL TRIANGLE) 
Figure 2 
 
Layers of the Urogenital Triangle 
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Progressing from superficial to deep (or inferior to superior), the 
urogenital triangle contains the following layers  
Skin and adipose layer: continuous with Camper’s fascia of abdomen 
Superficial fascia (Colles’ fascia) ( figure 3) 
 The irregularly membranous, often laminated layer of tissue deep to 
Camper's fascia is called Colles' fascia. It is the continuum of Scarpa's fascia in 
abdomen onto the perineum. It is laterally attached to pubic ramus and to the 
posterior edge of the urogenital musculature posteriorly. This provides an 
anatomic barrier between the urogenital spaces anteriorly and the ischioanal 
fossae posteriorly. 
Figure 3 
 
Superficial Perineal Pouch 
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The superficial perineal pouch includes the space between the fascia of 
Gallaudet and the perineal membrane. The perineal membrane provides a 
"roof" for the superficial pouch and a "floor" for the deep pouch (urogenital 
diaphragm). The perineal membrane is the inferior fascia of the urogenital 
diaphragm (figure 4). 
Figure 4 
 
It is composed of the following structures (from external to internal). 
External perineal fascia or muscle fascia of Gallaudet 
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Paired muscles  
• Ischiocavernosus 
• Bulbospongiosus 
• Superficial transverse perineus muscle 
OTHERS  
•  Crura of the Corpora cavernosa of penis. 
• Bulb of the penis or Corpora spongiosa. 
• In female Right and left vestibular (Bartholin) glands (Figure 5) 
Figure 5 
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The blood supply to the pouch is through Posterior scrotal/labial 
branches of the perineal branch of the internal pudendal vessels and Transverse 
perineal branch of the perineal branch of the internal pudendal artery 
(supplying the superficial transverse perineus muscle and tissue between the 
bulb and the anus). 
The infective process from urogenital tract may track down here and 
spread to rectum and ischiorectal fossa which are posteriorly and laterally 
related to the pouch. So the infection from urogenital tract may spread via the 
superficial perineal pouch to ischiorectal fossa and vice versa.  
But in majority of cases the infection originating from urogenital tract 
involves the penis and superficial perineal pouch not extending to the posterior 
half of perineum. The colles fascia acts as a barrier to limit the spread. The 
infections from colorectal sources extend from the perianal area to perineum 
then goes on to involve the anterior abdominal wall without much extension to 
penis.  
There is free space that exists between the external oblique aponuerosis 
and the Scarpa’s fascia. This permits the spread of infection from the perineum 
onto the anterior abdominal wall..The fascia of abdomen continues in the chest 
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wall till the clavicle and so the disease process can spread till the chest wall 
which had initially started in the perineum and scrotum.  
Cutaneous   blood supply of skin of the anterior abdomen wall and 
genitalia  
The superficial tissues of the lower anterior abdominal wall are supplied 
by 3 branches from main femoral artery. These branches, from lateral to 
medial, are the superficial circumflex iliac artery, the superficial epigastric 
artery, and the superficial external pudendal artery. The main trunk of these 
vessels and also the branches of these vessels traverses through the camper 
fascia and subcutaneous layer of abdominal wall. So it gets obliterated in the 
process of disease progression. This causes necrosis and sloughing out of 
tissues anterior abdominal wall (Figure 6).  
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LAYERS OF SCROTUM  
The scrotum houses the testes and the epididymis. It is composed of 
eight layers that are derived and modified from the six layers of the abdominal 
wall. Although the layers are continuous, their terminology changes as they 
pass from abdomen to scrotum(Figure 7) . 
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The subcutaneous superficial fascia in the scrotum contains little adipose 
tissue, this being replaced by smooth muscle that forms the tunica dartos scroti. 
The attachment of these muscle fibers to the skin forms the rugal folds of the 
scrotal skin. 
The scrotum is well supplied with blood. Branches of the superficial and 
deep external pudendal arteries supply the anterior part of the scrotum ( Figure 
8). 
Posterior part of scrotum is supplied by internal pudendal artery branch 
namely posterior scrotal artery. Since the internal pudendal does not travel 
through the camper fascia the area supplied by it namely the posterior scrotal 
wall remains intact. 
Figure 8 
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THE PENIS can be divided into three parts: the root, the body, and the 
glans. The root, or penile bulb, is located within the superficial perineal pouch, 
which provides fixation and stability. The body is formed by the three spongy 
erectile anatomic entities: two corpora cavernosa and one corpus spongiosum.  
The root, or penile bulb, is located within the superficial perineal pouch, 
it provides fixation and stability. The body is formed by the three spongy 
erectile anatomic entities: two corpora cavernosa and one corpus spongiosum. 
COVERINGS 
( Figure 9) 
The Skin that covers the penis is thin, with a very thin areolar layer 
which covers, or is mixed with, the superficial penile fascia. The distal part of 
the skin forms two anatomic entities, the foreskin (prepuce) and the frenulum.  
The superficial penile fascia is the downward continuation of the 
fasciae of Camper and Scarpa. It is without an adipose content, but with some 
smooth muscle fibers, like the dartos tunic of the scrotum.  
The tela subfascialis  a very thin areolar tissue layer. It occupies the 
interval between the superficial dartos tunic and Buck's deep fascia over the 
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extracorporal segments of the cavernous arteries, veins, and nerves. Also in 
this interval are the bilateral dorsal arteries, dorsal veins, and dorsal nerves.  
The deep penile fascia (fascia of Buck) covers the corpora cavernosa 
and spongiosum. The infection is limited by the buck’s fascia. 
The tunica albuginea is a thick white connective tissue matrix formed 
by two fibrous layers, the outer longitudinal and the inner circular, with little in 
the way of elastic tissue. It is strongly attached to the overlying fascia of Buck; 
or perhaps it is better to say that the fascia of Buck is firmly fixed to the tunica 
albuginea. 
 Figure 9 
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The arterial blood supply of the penis is formed by a superficial and a 
deep system. The external pudendal artery is responsible for the formation of 
the superficial system; the internal pudendal artery provides the deep system. 
 Superficial system (Figure 10) originates from the external pudendal 
artery (from the common femoral artery), which gives origin to a dorsolateral 
and a ventrolateral branch. These branches supply the skin of the penis. 
In deep system (Figure 11) the dorsal artery of penis can be regarded as 
the terminal continuation of the internal pudendal artery The dorsal artery 
leaves the urogenital diaphragm by piercing the transverse perineal ligament 
(the fusion of the superior and inferior fasciae of the diaphragm) and by 
passing onto the dorsum of the shaft beneath the superficial fascia. 
The beneficiaries of the dorsal artery are the corpora cavernosa, the 
corpus spongiosum, the tunica albuginea, and the urethra which are pierced by 
branches of the dorsal artery. The dorsal artery also gives off laterally directed 
circumflex branches which pass to the corpus spongiosum.  
 
FIGURE 10 
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FIGURE 11 
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Since the internal pudendal does not travel through the camper fascia the 
area supplied by it namely the posterior scrotal wall and erectile bodies’ 
remains unaffected so it can be used as a bed to place graft and flaps after the 
total remission of infective process. When the penis is involved, infective 
process involves skin and superficial penile fascia gets necrosed and sloughs 
off while the corpora and urethra are usually intact. 
Thrombosis and destruction of the corpara spongiosa and cavernosa has 
been reported (22).Intra abdominal and retroperitoneal infection spread can lead 
to testicular gangrene (34).  
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EPIDEMIOLOGY 
During the period from 1950-1999, 1726 cases was reported in all 
indexed medical publications. While between 2000 and 2007, 1571 cases have 
been documented. 
This apparent increase in the incidence of this disease may be accounted 
for by improved identification of the condition when encountered in clinical 
practice and also because of increased reporting of the disease in medical 
literature. 
 Other probable reasons could be an increase in the number of people 
with predisposing factors such as diabetes, renal failure and 
immunosuppression (HIV). The internet has an important role to play in 
disseminating information and creating awareness.  
AGE AND SEX 
Young men no longer seem to be the only section of the population 
affected by the disease. The epidemiology of the disease has changed so as to 
encompass a much larger spectrum of the population ranging from the neonatal 
age group going upto and including the very elderly.  
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 A review of pediatric literature reveals that of the 55 cases reported, 
two-thirds have been lesser than 3 months of age (9, 10). 
While during the period before 1945, the average age of the patients 
affected by the disease was about 40 years, 50-60 years seems to be the more 
commonly affected age group in recent times. 
Old age is an indirect predisposing factor to Fournier’s gangrene in that 
poor nutritional status and poor self-care, renders the elderly more susceptible 
to the disease. The prognosis is also poorer in them. 
Genital gangrene has also been reported in women. The disease involves 
the vulva, perineum, thigh and abdomen as well (11, 12, and 13). 
 Eke in his large scale meta-analysis, arrived at a male to female ratio of 
10:1. 
ETHINICITY AND SOCIAL CLASS 
While  poor socio economic conditions often  been quoted as important 
contributing factors to this disease, supported by a report from Europe stating 
that the civilized population don’t seem to be as commonly affected by 
Fourneir’s gangrene , Some case reports from affluent sections  of USA and 
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Europe beg to differ. They report that the disease affects both the poor and rich 
sections of the society. 
Fournier’s gangrene has been reported to be highly prevalent in African 
countries and South Asian countries.  
 There are two important etiological sources of sepsis for this condition. 
One is skin, while the other is colorectal/perineal infections. In the developed 
world, cutaneous infections are more common source of sepsis and it carries a 
better survival rate. The morbidity and mortality rates associated with the 
colorectal source are higher than that encountered with skin. The colorectal 
route is more frequent portal of entry in the developing countries like ours. 
PRE DISPOSING FACTORS 
Patients affected by Fournier’s gangrene have been found to commonly 
have an underlying systemic disorder, of which, DIABETES AND 
CHRONIC ALCOHOLISM seem to be the most frequently reported. 
Chemotherapy, leukemia, liver cell failure , colorectal cancer, carcinoma in 
other sites with immunosuppression also poses increased risks. 
 HIV represents a new risk factor in recent times among patients affected 
by this condition in the developed as well as the developing sections of the 
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world. In fact, among patients with undiagnosed HIV infection, it has been 
reported that Fournier’s gangrene could be the earliest presentation. 
In paraplegic patients bedsore in neighborhood of the scrotum, perineum 
and perianal regions is also a risk factor. 
 In all the above mentioned conditions, immnosupression and failure of 
T cell immunity leading to poor host resistance is the common factor. This 
followed by decreased oxygen tension and invasion of organisms which under 
ordinary conditions are commensal to the area, ultimately leads to gangrene (15).  
DIABETES AND FOURNIER’S GANGRENE 
Among the common systemic diseases encountered among the people in 
our country, diabetes mellitus has been found to rank high up in the list. True 
to this fact, 84% of the total number of patients who participated in this study 
was found to be diabetic. 
Diabetes mellitus causes tissue ischaemia by affecting the small blood 
vessels. It also causes urinary outlet obstruction, thus increasing the incidence 
of infection of the urinary tract. Other mechanism by which diabetes operates 
is by causing microvascular disease, affecting phagocytosis and reduction in 
cellular immunity. All this ultimately results in ischaemia.   
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ETIOLOGY 
Even though it has been emphasized in the original description of this 
disease that there seems to be no known cause accountable for this condition, 
further studies have lead to an understanding of the pathological processes that 
could possibly underlie the occurrence of gangrene of the genital and perineal 
regions.  
The anorectal region, urogenital tract and the skin of the genitalia have 
been proposed as common sites of the origin of infection which seem to set in 
motion the necrotizing process. 
• Anorectal causes - Perianal, gluteal, ischiorectal abscesses;anal 
fissures; inflammation of the appendix; (17) colonic perforations due to 
carcinoma, blunt injury and tuberculosis  (18, 19), colon and sigmoid 
diverticulitis and abscess (20).  
Urinary tract and External genitalia   
• Bulbourethral gland infection,  
• Injury to urethra following catheterization or trauma. 
• Stricture urethra and infection after manipulation with dialators.  
• Renal abscess(21), urethral calculi ,lower urinary tract infection 
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• Prosthetic penile implants (22), genital jewel piercing (23). 
Dermatologic causes –  
o Hidradenitis, chronic bedsore, tinea cruris and erypsilea. 
• In children -  following surgeries  like inguinal hernia with strangulation 
and obstruction, circumcision,  urethral manipulation and catheterization 
for diagnostic purposes , peri-rectal abscesses, rash due to diapers , and 
burns(24). 
• Increased risk is associated with Poor perineal hygiene and the presence 
of chronically indwelling catheters, for example in paraplegic patients.  
• Other surgical causes responsible for Fournier's gangrene – surgery for 
strangulated femoral and inguinal hernias , Thiersch  wiring , banding 
for pile mass (25), prostatic biopsy (26), femoral puncture for splenic 
angiography and also rectal foreign bodies(27).  
The above mentioned etiological factors permit the entry of the 
microorganisms responsible for this condition into the perineal region. The 
poor immune status of the host allows the infection to kick in while the disease 
spread is facilitated by the virulence of the microorganisms.  
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PATHOPHYSIOLOGY 
Fournier's gangrene development requires a source of infection and a 
portal of entry.The causative pathogens may have low virulence but act 
synergistically. Necrosis of skin and subcutaneous tissues occurs readily in 
scrotum and perineal tissues since it lacks subcutaneous tissues (28). There is no 
subcutaneous tissue between skin and dartos. 
Fournier’s gangrene involves multiple gram (+) and (-) organisms, these 
organisms are of low to moderate virulence but synergism causes them to 
progress to severe infections with tissue necrosis and gangrene. It has been 
believed by many authors that the rapid multiplication and spread of infection 
in Fournier’s gangrene is due to the polymicrobial nature of the infection 
which leads to synergistic enzyme production. For example, one organism can 
cause coagulation of subcutaneous vessels which leads to tissue hypoxia which 
allows and hastens the growth of facultative anaerobes and microaerophilic 
organisms. Lechithinase and collagenase are produced by these organisms 
which lead to rapid spread of the infection due to digestion of fascial barriers. 
The pathology includes necrosis of superficial fascial layers and the 
surrounding tissues: the deep fascia however is not involved and spared. 
PATH OF SPREAD IN FOURNIER GANGRENE 
THROUGH UROGENITAL ROUTE 
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• Initially there is infection of paraurethral glands and there is necrosis of 
skin and subcutaneous layers. The infection is prevented from further 
spread by the Buck’s fascia. Once the Buck’s fascia is breached, the 
infection spreads along the plane of Scarpa’s.  
• Upward spread thro scarpa fascia is more common than downward 
spread to perineum through  Dartos’ and Colle’s fascia. 
THRO PERINEUM AND RECTAL ROUTE 
• Perirectal infections reach near the Sup. Perineal pouch and spread 
through the Colle’s fascia into the testis and scrotum. 
FROM THE SKIN 
• Trauma and pressure in the perineal tissues due to sitting and tight 
undergarments result in the spread of bacteria from the skin into the 
subcutaneous tissue (29).. 
 
The pathognomonic pathological features of affected tissue are: 
• Fascial layers necrosis. 
• Fibrinoid coagulation of the nutrient arterioles  
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• Infiltration of leukocytes. 
• Gram staining and culture may identify and isolate microbes from 
specimen. 
BACTERIOLOGY 
Fournier’s gangrene is a polymicrobial infection with cultures from the 
wounds of affected patients showing 2-3 microbial species per case. 
Aerobe which was commonly isolated is E.coli  and anerobe commonly 
isolated was Bacteroides spp.  
Frank L.  Meleny during World War I reported in China a case series of 
necrotizing infections and found streptococcal species to be the most common 
organisms in culture. After his publications Meleney and many others imputed 
streptococcal species as the sole pathogen for the development of necrotizing 
infections; however, subsequent clinical series asserted the polymicrobial 
nature of the all necrotizing infections, including Fournier gangrene.  
Currently isolation of a single organism is very rare and there are about 
4 different bacterial species commonly isolated along with streptococcus 
(staph., anaerobic strep, bacteroides and enterobacteriae spp. pseudomonas and 
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klebsiella) (31).  Lactobacillus gasseri and Candida albicans(32) have also been 
rarely reported in culture. 
Clostridium perfringens, has occasionally been isolated (33). There have 
been isolated reports of sarcoptes scabeii and wucherira being isolated. 
CLINICAL FEATURES 
 The typical patient is an adult male in of 50-70 years with characteristic 
predisposing factors. Females are less commonly affected by this disease. 
The hallmark of Fournier’s is exquisite pain and tenderness in the 
genitalia, scrotum and perineum. The disease usually progresses through these 
phases:  
1. Malaise and intermittent fever are the initial prodromal symptoms which 
may last from two days to a week before the appearance of skin changes. 
2.   Intense pain and tenderness over the scrotum and perineum follows 
next, along with the appearance of edema of the overlying skin. The 
intensity of the pain experienced may initially be out of proportion to the 
findings. It  is due to cellulitis and accumulation of fluid.(COLOUR 
PLATE 1) 
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3. Pain and tenderness in local area progressively increases along with 
erythema of the overlying skin. 
4. The overlying skin starts becoming dusky along with appearance of 
crepitations in the subcutaneous tissue. 
5. Lastly Frank gangrene may appear in a region of the perineum and 
genitalia, Pus starts draining from wounds (COLOUR PLATE II). 
6. The spectrum of disease ranges from only local symptoms with no 
sepsis to frank septicemia with SIRS and MODS. It primarily depends 
on area of involvement and virulence of organism. The host factors are 
also responsible for this varied spectrum. 
 
 
FOURNIER GANGRENE INTIAL STAGE.(COLOUR PLATE 1) : 
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COLOUR PLATE II 
PUS DRAINING OUT THROUGH WOUND 
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INVESTIGATION 
Fournier’s gangrene diagnosis is essentially clinical and there is no 
role for additional imaging and blood investigations to confirm the 
diagnosis and this should not defer and impede the initiation of definitive 
therapy. 
Lab Studies 
The lab abnormalities are used to assess the severity and guide to 
resuscitate the patient preoperatively as most present with severe metabolic 
disturbances. 
Complete Blood Count and Renal Function Test 
• For the evaluation of electrolyte derangements. 
• Findings suggestive of azotemia.  Elevated  urea and creatinine  
• White cells count to assess the host response to infection. 
• Hematocrit may be increased due to dehydration and in late stages of 
septic shock it may be low. 
• Blood sugar levels may be very increased in diabetics causing 
ketoacidosis . 
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Liver function test 
• Exacerbation of preexisting liver failure. 
• Sepsis induced hyperbilirubinemia and hypoalbuminemia. 
o Blood cultures for the identification of any sepsis. 
o For the detection of any sepsis induced coagulopathy, a coagulation 
profile would serve the purpose (platelet count,  fibrinogen level, 
PT,aPTT and INR ) 
Others 
Any investigation for the assessment of an associated comorbidity and 
as a part of preoperative anesthetic workup is justified. (eg, chest x ray, ECG, 
blood group and type) 
  
48 
 
FOURNIER’S GANGRENE SEVERITY INDEX 
In calculating the Fournier gangrene severity indexes score, 9  
parameters are measured. 
Vital parameters Temperature; Heart Rate; Respiratory Rate; 
BLOOD VALUES 
Serum Electrolytes namely Sodium, Potassium, and Bicarbonate levels;  
Hematocrit and white cell count, Creatinine value. 
A score was given to each factor based on its variation from normal 
value. So blood was drawn to measure these parameters. The individual values 
are summed to obtain the FGSI score.  
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IMAGING IN FOURNIER GANGRENE 
X RAY OF LOCOREGIONAL AREA 
Conventional radiography is indicated when the findings by physical 
examination are not definitive. Radiography is more reliable for the detection 
of gas within the soft tissues. 
Surgical exploration is definitely indicted when there is subcutaneous 
crepitus or gas in the soft tissues. 
Gas in the soft tissues over the scrotal and perineal regions may be seen 
in X-rays as hyperlucencies. Inguinal regions, thighs and anterior abdominal 
walls are other regions also affected by subcutaneous emphysema that has 
spread from the scrotal and perineal regions (COLOUR PLATE III). 
 However, upto 10% of patients finally diagnosed with Founier’s 
gangrene did not have air in the subcutaneous tissues overlying the perineal 
and scrotal regions(35).   
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COLOUR PLATE III 
 
  
51 
 
ULTRASONOGRAM OF ABDOMEN, SCROTUM AND PERINEUM 
• A thickened scrotal wall with hyperechoic foci due to gas, is seen on 
ultrasonography as “dirty” shadowing(COLOUR PLATE IV). 
• Clinical evidence of crepitus is usually preceded by radiographic 
evidence of gas in the scrotal wall. There is also a possibility of 
occurrence of hydroceles unilaterally or bilaterally.  
•  An intra-abdominal or retro-peritoneal source of infection may be 
responsible for testicular involvement which can be identified in 
ultrasound. 
• Inguinoscrotal incarcerated hernia may be differentiated from Fournier’s 
gangrene by ultrasonography by the presence of gas in the obstructed 
bowel lumen, rather than the gas in scrotal wall. 
•  If a diagnosis of testicular torsion is being considered, Ultrasonography 
may be useful in assessing the testicular blood flow.  
 
• COLOUR PLATE IV 
• ULTRA SOUND OF SCROTUM 
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•  
• ARROW SHOWING SCROTAL WALL EDEMA 
• CURVED ARROW SHOWING HYPERECHOIC AREAS 
 
 
 
 
 
 
 
 
 
 
 
CT scanning 
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CT will prove to be useful, in patients in whom the diagnosis is in doubt 
or the disease extent cannot be made out clearly clinically with certainty. For 
the assessment of disease extent, CT is more specific than ultrasound or Xrays. 
Progressive infiltration of soft tissues can be seen on CT in early stages 
of Fournier’s gangrene even before the appearance of subcutaneous 
emphysema.  
Findings suggestive of Fournier’s gangrene on CT are: 
• Thickening & inflammation of soft tissues. 
• Fluid collection/abscess 
• Stranding of fat around affected structures 
• Asymmetrical fascial thickening 
• Subcutaneous emphysema caused by gas forming bacteria(COLOUR 
PLATE V) 
In this condition, the subcutaneous emphysema spreads along fascial 
planes, reaching as far out as the anterior abdominal wall, thighs, 
retroperitoneum and thoracic wall which can visualized with CT scanning. 
(COLOUR PLATE VI) 
COLOUR PLATE V 
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CT SHOWING GAS IN SCROTUM EXTENDING TO INGUINAL 
REGION 
 
COLOUR PLATE VI 
 
CT SHOWING EXTENSION TO PARARENAL SPACES 
TREATMENT 
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Fournier’s gangrene is a surgical emergency. The therapy involves 
preoperative hydration and Hemodynamic stabilization , administration 
of broad spectrum antibiotic  and   urgent and immediate surgical 
debridement of necrosed area .  
The most important aspect of management is  urgent Surgical 
Debridement since the necrosis spreads very rapidly. The rate of spread of 
infection can be as high as two centimeters in one hour(37).. 
The antibiotic administration should start immediately on admission 
which should cover and be effective against staph. strepto and coliforms. A 
separate antibiotic administration should be added to cover anaerobes. 
Urgent resuscitation with fluids as well as blood transfusions may be 
needed.  
The disease left in its course of events leads to regeneration of scrotum 
skin and epitheliazation and scar formation (38).There are reports of complete 
healing and skin closure without any need for further surgeries (39,40). 
PHARMACOTHERAPY  FOR HEMODYNAMIC OPTIMIZATION 
The two motives of the medical treatment are restoration of organ 
dysfunctions and treatment of the infection.  
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Most of our patients present late to the hospital, hence they are 
dehydrated and present with features of systemic sepsis. There is an absolute 
need for urgent restoration of organ perfusion and correction of dehydration 
and electrolyte disturbances before the surgery. 
Ionotropic support may be needed in cases of hypotension. Nor 
adrenaline is needed in cases of septic shock. 
Treatment also involves the institution of broad-spectrum antibiotic 
therapy. Providing coverage for grampositive, gram-negative, aerobic, and 
anaerobic bacteria is essential. The antibiotic spectrum should cover 
staphylococci, streptococci, the Enterobacteriaceae family of organisms, and 
anaerobes. 
Penicillin group of drugs like Ampicillin is used to cover streptococci 
while metronidazole is given against anaerobes such as bacteroides. A broad 
spectrum antimicrobial agent, preferably the third generation Cephalosporins 
combined with Aminoglycoside amikacin or gentamicin is used against gram 
negative organisms such as the coliforms. 
Clindamycin may be used as it is shown to suppress toxin production 
and modulate cytokine production. Linezolide and daptomycine, tigecycline is 
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warranted in cases of previous hospitalizations with prolonged antibiotic 
therapy which may lead to resistant bacteroides. 
New clinical guidelines currently recommend the use of Carbapenems 
(Imipenem, meropenem, ertapenem) or piperaziline-tazobactam. These newer 
drugs have larger distribution and lesser renal toxicity in comparison to 
aminoglycosides. A relook at the classical triple therapy should be done and 
this should be replaced by newer drugs as and when required.(40). 
If fungi show up on initial tissue stains like potassium hydroxide stain or 
it is grown in culture an antifungal like caspofungin or amphotericin B  should  
be added. 
 Intravenous immunoglobulin therapy has been found to be a good 
adjunct in sepsis following proper surgical debridement and good antibiotic 
cover and it is found to hasten the recovery. 
SURGICAL MANAGEMENT 
• DIAGNOSIS IN DOUBTFUL CASES 
• In patients clinically when there is a suspicion of fournier , a definitive 
diagnosis is arrived at by incising and examining the most suspicious 
area under anaesthesia.  
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• Sometimes before the appearance of gangrene , the disease presents as 
severe cellulitis. In such cases, the fascia appears edematous rather than 
the typical gray-black appearance on surgical incision and removal of 
overlying skin.  
• On finding Frank gangrene and/or purulent material in subcutaneous 
tissue it establishes the diagnosis. 
• RADICAL REMOVAL OF NECROTIC AREAS (COLOUR 
PLATE VII & VIII) 
o Skin may be deroofed or multiple incisions may be made to lay open the 
subcutaneous layer.  This allows the exudates to come out also allows us 
to inspect the progress of disease.          
o  Excise and remove completely all necrotic non-viable tissue until viable 
well-perfused tissue is visualized 
COLOUR PLATE VII 
INTIAL PRESENTATION 
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POST DEBRIDEMENT SPC DONE FOR URINARY DIVERSION 
 
 
 
 
 
 
 
COLOUR PLATE VIII 
AT OPD FOURNIER GANGRENE PATIENT 
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POST DEBRIDEMENT (Patient catheterized for diversion) 
 
PICTURE AFTER 15 DAYS 
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The cutaneous involvement underestimates the actual spread of the disease as 
it is less than the subcutaneous tissue involvement.            
o Tissue should be sent for hispathological examination and culture for 
anaerobic and aerobic organisms. 
o The extent of the disease and necrosis should be reassessed as the 
disease may progress and also intial debridement may not be complete 
due to poor general condition of the patient. 
o  Repetitive operative debridement at a later date may be necessary to 
ensure removal of infective focus and gangrenous areas. 
o Antibiotics are guided based on wound and tissue culture and sensitivity. 
It must be continued for 10-14 days or till healthy granulation appears.  
REQUIREMENT OF ORCHIDECTOMY 
• Involvement of the testes is a documented complication in Fournier’s 
gangrene, in spite of the fact that the testes have their own independent 
blood supply. The need for orchidectomy arises when the infective 
process spreads to the retroperitoneal from the intra abdominal 
compartment. Retroperitoneal spread foretells poor prognosis.  
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• Upto 21% of patients in some series have required orchidectomy surgery 
for non-viable testes. 
DIVERSION PROCEUDRES  
In cases where there is widespread perineal involvement and constant 
fecal soiling, a colostomy may be needed to reduce wound contamination by 
faeces. 
Fecal diversion  
• In patients with severe perineal involvement, colostomy has been 
resorted  for fecal diversion. The logic behind this approach is the 
involvement of the anal sphincter by this condition leading on to fecal 
incontinence and contamination of the wound margins by feces. 
•  Hence when a rectal diversion is done, it would facilitate 
better wound healing by causing a net reduction in the 
number of microorganisms infecting the perineal region. (COLOUR 
PLATE IX) 
• COLOUR PLATE IX 
Case requiring colostomy 
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Rectal diversion devices  
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•  The Flexi-seal Fecal Management system functions in the same way as 
a colostomy to prevent fecal contamination of wounds. It is a catheter 
made of silicone which serves for fecal diversion in patients with 
diarrhea, local burns or skin ulcers. 
• Estrada et al found it to be an effective alternative to colostomy. The 
anal canal should be examined prior to catheter placement. It also offers 
advantages over stomas in terms of cost effectiveness and recovery of 
the patient psychologically. 
• \\ The presence of stricture or stenosing lesion or presence of carcinoma 
precludes the use of this device. 
Urinary diversion.  
• Penile and urethral involvement necessitates urinary diversion. Urinary 
catheterization is sufficient in some cases. Supra pubic cystotomy needs 
to be done in cases with stricture urethra and cases with BPH 
(COLOUR PLATE X). 
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COLOUR PLATE X STRICTURE URETHRA WITH SPC 
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Topical therapy 
• When unprocessed natural honey was applied over debrided areas, it 
produced good results within a week of application by virtue of its low 
pH (3.6) and necrotic tissue digesting enzymes. 
• Post operative application of hydrogen peroxide and use of 0.5% sodium 
hypochlorite have been advocated. 
• Application of lyophilized collagenase as a form of enzymatic 
debridement has also produced favourble results. 
Local negative pressure treatment (VAC) 
The wound VAC device is a form of occlusive dressing that is applied 
around a sponge placed immediately over the wound. Through an opening in 
the occlusive dressing suction is applied through tubing connected to a 
negative pressure device. It needs to be shaped so as to fit into irregular 
wounds and cavities. It is advisable to change it once in 2-3 days. It serves to 
promote granulation tissue formation, improves local blood flow and brings 
down the oedema. Going by the number of reports, VAC seems to be 
increasingly used for patients with Fournier’s gangrene(47,48).  
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Advantages stated are: 
(a)   There is decreased need for repeated debridements. 
(b)  One time reconstruction can be accomplished because of the reduction 
in raw area and appearance of healthy bed for better graft or flap 
survival.  
VAC also has the advantage of  promoting  the uptake of skin graft by 
holding the graft in situ and preventing the accumulation of blood or fluid 
beneath it.  
Disadvantages associated with this device are the need to immobilize the 
patient and high cost. 
Hyperbaric oxygen therapy  
• This is a method of improving oxygenation to the arterial and tissues by 
making the patient breathe 100% oxygen while he is put in an 
environment of high ambient pressure. 
• It inhibits growth of anaerobic organisms, promotes fibroblast 
proliferation and angiogenesis, facilitates intracellular transport of 
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antibiotics, optimal neutrophil phagocytic function and reduces edema 
by vasoconstriction [43] .  
• Hyperoxia promotes transmembrane transport of aminoglycosides 
through an oxygen dependent pump increasing its efficacy.   
• Possible side effects reported are barotrauma to middle ear and CNS 
toxic effects.  
• Hyperbaric Oxygen Therapy continues to be a matter of debate till date. 
Nutritional support 
• Stress in septicemia patients causes a phenomenal increase in basic 
energy requirements. Multiple surgical procedures and mechanical 
ventilation rules out oral intake as a possible source of energy.  
• In this situation, total parenteral nutrition alone may not ensure adequate 
calorie intake. Studies have revealed that critically ill patients have 
calorie requirement of about 125% of the basal quantity. This can be 
ensured by additional enteral intake.  
• The theoretical benefit of the intake of oligoelements (like arginine, 
citrulline and glutamine) has been discussed in many articles.  
• Low plasma concentrations of L-arginine, documented in these patients 
has been correlated with poor outcomes. This is because ariginine 
promotes wound healing and improves the immune function. 
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COMPLICATIONS 
 
Renal function 
• Due to septicemia and release of toxins to the blood stream there is renal 
failure in most patients. Most cases are managed by fluid management 
and other conservative measures. 
• Some cases require hemodialysis to manage the acute renal failure. 
• Intravenous albumin is found to improve the survival and also hasten the 
recovery in cases of septicemia 
There may be UNRELENTING SEPSIS despite surgical debridement 
which may be due to the following factors: 
• Incomplete removal of infective process causing progress and ascend of 
necrosis. 
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• There may be other focus of infection which is not identified initially, 
for example colonic diverticular abscess or hollow viscus perforation. 
• Sepsis induced Acute respiratory distress syndrome. 
• Pnuemonia and lung collapse due to chronic bed confinement.  
• Deep vein thrombosis and pulmonary embolism due to prolonged 
immoblisation and associated risk factors like carcinoma.  
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Causes of mortality are given below: 
 
MORBIDITY DUE TO FOURNIERS 
 Morbidity due to Fournier’s disease varies corresponding to the hospital 
stay duration which ranges from 2 days to a reported maximum till around 280 
days (44). 
Although spontaneous healing with simple dressing has been reported, 
others advocate avoiding it, as there may fixity of testis to perineum and 
surrounding structures and immobilization could result by it.  
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OUTCOME AND PROGNOSTIC FACTORS 
 
Extent of involvement, associated comorbidities,pre hospital symptom 
duration are important prognostic factors. Any undue delays in diagnosis and 
initiation of treatment also determine the final outcome. The severity index 
score has a definitive role in predicting the mortality and morbidity. 
The death rate in Fournier’s gangrene is lesser than that is associated 
with other forms of necrotizing fasciitis and is probably due to the gravity 
dependent drainage that occurs in perineum and scrotum. The mortality rate in 
Foumier's gangrene varies from 3 to 30 per cent.  
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FOURNIER’S GANGRENE SEVERITY INDEX 
There are many independent prognostic factors described to predict the 
mortality for Fournier gangrene namely, Diabetes, advanced age, primary 
anorectal source of infection, delayed presentation, systemic sepsis on 
admission. 
Laor et al. in 1995 and designed the FGSIS (Fourniers’s Gangrene 
Severity Index Score) which is a modification of the already known APACHE 
II (Acute Physiology and Chronic Health Evaluation II) in which they found 
that patients with a score around 7 survived and  score greater than nine had 
significant mortality . 
The score has an advantage that it can be very easily calculated based on 
vital parameters and basic blood parameters. No sophisticated investigations 
and cost is involved in it. Lower cost factor offers advantage to this group of 
patients because the disease commonly affects lower socioeconomic status. 
Laor et al reported that a score greater than nine had mortality as the 
outcome with positive predictive value of 80%. The score below nine had 
probability that they survived. This cutoff point has been achieved through 
ROC curve in many other studies. In many subsequent studies the value of 
score which best predicted mortality was nine. So a score above nine should 
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alert the treating surgeon to pursue aggressive resuscitative measures and 
radical surgical drainage.     
Specific metabolic parameters (serum albumin and alkaline 
phosphatase), predisposing factors and disease extent should be assessed 
together to predict treatment outcome and survival. 
It has been proved that survived patients had significantly higher serum 
albumin consequent to better patient’s metabolic reserve. 
Noteworthy, FG has predilection towards immune dysfunction, and 
patients who had a higher IL-2 level had more survival (45).  Interleukin is 
proved to play a role in augmenting the host response and hence restricting the 
infection.  In a study the IL-2 value was added to FGSI score and a cutoff for 
mortality was detected(46). 
Abdul Samad in 2007 devised a new system to predict mortality  in 
which the extent of involvement and platelet count value was calculated and 
added to the already mentioned  FGSI score (COLOUR PLATE XI) 
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He proved in his study that score on admission > 12 has high chance of 
mortality. Since the sample size was small there was not any statistical 
significance to the result. It needs to be reevaluated at a large scale study to 
prove its usefulness and to accept it in future.  
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COLOUR PLATE XI 
FOURNIER GANGRENE IN PLHA PATIENT WITH EXTENSIVE 
INVOLVEMENT OF THIGH AND PERINEUM 
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RECONSTRUCTION 
Wound cover is achieved by following means 
o Healing and epithelisation without grafting(COLOUR PLATE XII) 
o Secondary skin closure.  
o SSG to the raw area. 
o  Testis implantation into thigh 
o Orchidectomy and skin closure( In elderly ) 
o Medial thigh flap 
RECONSTRUCTION 
• Placement of bare testes in the medial part of thigh in subcutaneous 
plane. It has higher success rate , short operative time and needs no 
much surgical skill. Young individuals may find it unacceptable , there 
is chance that higher temperature in thigh may affect fertility. 
(COLOUR PLATE XIII). 
• In consenting older patients the option of orchidectomy and skin closure 
can be done. But patient may be psychologically affected due to loss of 
testis and affect his sexual function (COLOUR PLATE XIV). 
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•  Split thickness skin graft can be put over exposed testis but the 
disadvantage is the movement of testes is lost and it gives a sticky feel 
when the raw surface is adhered to the graft. 
•  Tight undergarments should be avoided because it may cause constant 
friction of  graft and then make it prone to infection. 
• Rotation flap from thigh can be used to cover the testis. cutaneous 
supply to the skin is maintained so it is sensitive to touch sensation. 
Patients have a good space enabling free movement of testes (COLOUR 
PLATE XV). 
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COLOUR PLATE XII 
Healing and epithelisation without grafting 
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COLOUR PLATE XIII 
BARE TETSTES POST DEBRIDEMENT 
 
 
MEDIAL THIGH POUCH PLACEMENT 
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COLOUR PLATE XIV 
AFTER ORCHIDECTOMY PRIOR TO CLOSURE 
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COLOUR PLATE XV 
HARVESTING A THIGH FLAP 
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OBSERVATION AND RESULTS 
The study was conducted in surgical wards of Govt. Stanley Medical 
college hospital. The following are my observations regarding the 
epidemiology and etiological , clinical features and treatment of patients 
affected with Fournier’s gangrene. 
AGE AND SEX 
The following table (TABLE 1) gives the age distribution of the 
patients. 
TABLE I 
AGE 
GROUP 
SURVIVORS 
(n=29) DECEASED(n=6) % GROUP 
40-45 4 NIL 11.4 
45-50 6 NIL 17.1 
50-55 9 NIL 25.7 
55-60 2 1 8.5 
60-65 2 3 14.2 
65-70 3 1 11.4 
70-75 2 0 5.7 
75-80 1 1 5.7 
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The average age of patients in this study was 56.5 ± 10.2 years. 
Mean age of all patients 
N Mean Std. Dev 
AGE 35 56.57 10.296 
   
The mean age of survivors was 54.6 and mean age of deceased patients 
was 65.8 years. (GRAPH I) 
In the study 34 patients were male and we had one was female 
patient.(GRAPH I  ) 
GRAPH I 
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PREDISPOSING FACTORS 
The risk factors found in these patients were diabetes, chronic renal 
failure and immunosuppression. 
• 30 patients were found to be diabetic and it is the most common 
underlying disorder in this group of patients i.e. 85% of the subjects. 
• Pre existing chronic renal failure was found in 4 patients and 2 patients 
had HIV sero-positivity. 
• Alcoholism was common denominator in most of the patients. 
•  2 out of 35 patients had no pre existing disease. 
•  5 out of 6 patients who died had diabetes. 
 PRE D
FA
DIA
CH
RENA
IM
SUPPR
V/C
N
ALC
 
1
1
2
2
3
Fr
eq
ue
nc
y
ISPOSIN
CTORS 
BETES 
RONIC 
L FAILUR
MUNO 
ESSED(H
ANCER) 
ONE 
OHOLISM
0
5
0
5
0
5
0
Di
G TOT
AL 
30 
E 4 
I 2 
2 
 
abetes 
25
5
PRE D
TAB
SURV
n
GRA
Chron
fai
ISPOS
LE II 
IVORS(
=29) 
25 
1 
1 
2 
PH II 
ic renal 
lure
1
3
ING FAC
NO
SURVIV
n=
5
3
1
0
Immu
suppre
1
1
TORS
N
S
N 
ORS(
6) 
 
 
 
 
no 
ssed 
on Surviv
urvivors
86
% OF 
TOTAL 
85.7 
11.4 
5.7 
5.7 
  
ors
 
87 
 
 
ETIOLOGY 
A recognizable etiological factor was found in 65 % of cases i.e.23 
cases. 12 cases had no etiological source. 
The most common source of infection was from the colorectal area. 15 
cases had colorectal etiology of which 10 were due to peri anal abscess.2 cases 
had fistula in ano as the previous etiological factor.  
Rectal carcinoma was found in 2 cases. 1 case was already receiving 
chemo radiation for the cancer. Another had received chemo radiation before 1 
year and lost follow up after that. 
In 1 case there was post radiation induced tinea cruris which was the 
etiological factor. In patients with HIV(2 cases), cutaneous infection was 
instrumental in initiation and propagation of infection. 
1 case had indwelling catheter for past 6 months (for BPH) following 
which he developed Fournier’s gangrene. 
Among the deceased the most common causes was from colorectal 
sources. 
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DURATION OF SYMPTOMS 
The   symptom onset is defined as the appearance of gangrenous 
changes, purulent discharge in skin, and elicitation of fluctuation. Most of the 
patients in this study presented late after the development of symptoms. Mean 
duration of symptoms in all the subjects was 2.99 days with a standard 
deviation of 1.13 days  
TABLE IV 
N Mean Std. Dev 
DURATION OF 
SYMPTOMS(DAYS) 35 2.99 1.128 
 
The mean duration of symptoms among the survivors was 2.66 days and 
mean duration of symptoms among deceased was 4.58 days.  
Mean duration among survivors and deceased with standard 
deviation(TABLE V). 
TABLE V 
Variable MORTALITY N Mean Std. Dev P-Value 
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DURATION OF  
SYMPTOMS 
(DAYS) 
No 29 2.66 0.877 
<0.001 
Yes 6 4.5 0.801 
Late presentation i.e. increased duration of symptoms before 
presentation to hospital was associated with increased mortality and this was 
found to be statistically significant. 
GRAPH IV 
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CLINICAL FEATURES 
In all patients there was history of preceding symptoms of pyrexia, 
myalgia and lethargy which varied between 2-5days.  
They also had history of  pain in the local area throbbing in nature due to 
collection of pus . This was followed by obvious gangrene of portion of 
genitalia and turbid discharge and sloughing out of skin with exposure of 
underlying structures. 
Local gangrene without features of systemic sepsis was found  only in 
14 patients. 21 patients had signs of sepsis as evidenced by tachycardia, fever, 
respiratory distress and  renal failure . Sepsis was more  noted in elderly 
patients, those with delayed consultation and those with co morbid disease like 
diabetes, alcoholics etc,. 
The extent of gangrene varied in each patient(TABLE VI). Being a 
spreading infective process, the gangrene was either involving the part or 
whole of scrotum and some with extension to the penis, perineum, thigh and 
anterior abdominal wall. 
 In this study, gangrene was confined to scrotum in only 8 patients, with 
extension into perineum in 20 patients. 4 patients had spreading extensive 
gangrene to the perineum, medial aspect of thigh. 3 cases had extension to 
anterior abdominal wall. 
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LAB STUDIES 
Laboratory investigations were done to assess the extent of systemic 
toxicity. We looked for electrolyte disturbances, glucose levels, and presence 
of ketosis, urea creatinine values to assess organ dysfunction.    
Approximately 72% of patients had raised urea, creatinine values, 
suggestive of pre renal azotemia, on the day of admission. 26 out of 35 patients 
had Acute Kidney injury on admission. Six patients needed hemodialysis. Rest 
of the patients the renal dysfunction resolved with fluid management and 
treatment of sepsis namely surgical debridement and antibiotic therapy.  
Diabetic ketoacidosis was present in 8 cases. Uncontrolled DKA due to 
sepsis was the cause of death in one patient. 
Wound swab and pus culture and sensitivity were sent for all patients on 
admission and thereafter during hospital stay at 5 days interval. 
The organisms isolated were Streptococci, E.coli, Pseudomonas, and 
Klebsiella and cogulase negative Staph. aureus. 
TREATMENT 
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The mainstay of treatment of patients with fournier gangrene is pre 
operative resusicitation, surgical debridement and antibiotic therapy. 
Debridement resulted in exposure of testicles in patients with extensive 
involvement of scrotum.   
Regular cleaning and dressing with hydrogen peroxide and povidone 
iodine solution was done for all patients, until healthy granulation appeared. 
In 2 patients, Orchidectomy was done. In one  case it was due to 
involvement of testes due to spread of disease to retroperitoneum. In other case 
orchidectomy and the skin closure was done during reconstruction. 
Colostomy for fecal diversion was needed in two cases. In both cases 
reversal was done after three months. 
Suprapubic cystostomy for urinary drainage and diversion was done in 3 
cases. Three had stricture urethra and had extensive penis and perineal 
involvement where catheterization was not possible. 
Out of 35 patients the following were the reconstructive procedures 
adopted. 
TABLE VII 
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Healing and epithelisation without 
grafting  
6 20% 
Secondary skin closure  13 44% 
Skin grafting  5 17% 
Testes placement in Medial thigh 3 10% 
Flap cover  2 6% 
 
In patients with exposed testicle, medial thigh implantation of testis was 
done in 3 cases and in 2 patients medial thigh flap was done a reconstructive 
procedure.  
COMPLICATIONS  
 The common complications were Acute kidney injury and septicemia. 
 26 out of 35 patients had evidence of pre renal azotemia on admission. 
About 6 patients needed hemodialysis. 
 All patients (6/35) who died had acute renal failure and there were two 
patients among them who underwent Hemodialysis.  
 Systemic Sepsis was seen in 21 patients. It was immediate cause of death in 
one patient. 
FOURNIER’S GANGRENE SEVERITY INDEX SCORE 
The FGSI score was calculated based on clinical examination and lab 
values.The mean score of all patients in this study was 5.49.  
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TABLE VIII 
N Mean Std. Dev 
FGSI SCORE 35 5.49 4.798 
 
The mean score of survivors were 3.72 and the mean score of deceased 
where 14. This score predicting mortality was found to be statistically 
significant. Mean score among survivors and deceased.  
TABLE IX 
 MORTALITY N Mean Std. Dev P-Value 
FGSI SCORE 
No 29 3.72 2.763 
<0.001 
Yes 6 14.00 2.966 
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ROC CURVE analysis was done find out the best cut off point of FGSI 
SCORE which predicts the mortality. 
GRAPH VII 
 
Area under the Curve = 1.000 
The ROC curve analysis predicted that the FGSI score of 11 or more will 
predict the non-survival status. 
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TABLE X 
FGSI SCORE 
MORTALITY
Total 
Yes No 
 
≥ 11 6 0 6 
<11 0 29 29 
Total 6 29 35 
 
TABLE XI 
Estimate Lower - Upper 95% CIs 
Sensitivity 100% 61.0, 100.0 
Specificity 100% 88.3, 100.0 
Positive Predictive Value 100% 61.0, 100.0 
Negative Predictive Value 100% 88.3, 100.0 
Diagnostic Accuracy 100% 90.1, 100.0 
 
A FGSI score of 11 on admission best predicted the mortality in our 
study. 
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DISCUSSION 
The age group defined initially by Fournier was young male. In 1940 the 
average age group affected was found to be around 40 years. . However in 
recent case series and large scale studies it was found that pre disposed ages 
was from 50-70 years. The average age in our study was found out to be 56 
years. 
The reason why old age is predisposed is they possess all risk factors 
required for the development of disease.  
Age was described as a independent risk factor in the literature by 
Kamer et al, Bosglu et al. It was observed in their studies that subjects with 
Age > 60 years had increased chances of mortality. 
The mean age of deceased in our study was 65.8 years (p value 0.013) 
( TABLE XI). 
TABLE XI 
 OUTCOME N Mean Std. Dev P-Value 
AGE 
SURVIVORS 29 54.66 9.954 
0.013 
 DECEASED 6 65.83 6.463 
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The male female ratio in this disease in most series was found to be 
10:1. There are many isolated case reports of fournier’s gangrene in female.  
But it was eke who formally calculated the sex ratio in a metaanalysis of over 
thousand seven hundred cases.  
There was one female case among 35 patients. She had initially a vulval 
abscess (cutaneous source of infection) which progressed to Fournier’s. 
PRE DISPOSING FACTORS 
The most common underlying disorder is diabetes and the first reported 
case in 1700 s was probably a diabetic. Diabetes was found in about 85% of 
our cases. In most studies there were about 75-80% of patients affected with 
diabetes. 
Korkut , Unalp and Eke defined diabetes as a independent risk factor. 
5 out of 6 patients who died had diabetes. Diabetes in our study was 
found to be a significant risk factor which predicts mortality. 
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TABLE XII 
SURVIVORS % 
DIABETIC(n=30) 5(14.2) 25(71.5) 85.7 
NON DIABETIC 1(2.9) 4(11.4) 14.3 PVALUE .0144 
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Preexisting chronic renal failure was found in 4 patients (11.4%).  
Patients affected with HIV are a new sub group where the incidence is 
increasing Elem et al reported the impact of HIV virus on fournier’s gangrene 
in Africa. He noted that in this sub group younger patients are affected and 
they had the gangrene process extensive and spreading to anterior abdominal 
wall and thigh. Fournier’s gangrene  had increased predisposition in second 
stage of disease(WHO nomenclature) where there is decreased CD 4 count. 
2 patients in our study had HIV seropositivity. They were aged 41 and 
40 years. One belonged to upper socioeconomic class (Mech. Engineer from 
Sikkim) and he was only one who belonged to upper social status in the whole 
study.  Both of them had extensive involvement beyond perineum. One patient 
was already receiving ART therapy during presentation. His CD4 count was 
375/mm3. Other patient CD 4 count (298 / mm3) was done after admission and 
he was started on ART. 
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When more than two co morbidities are found in same  patient it was 
found to have a significant impact on survival (Corcoran et al, basoglu et al 
and Yanar h et al).In our study more than two co morbid illness was found in 
18 subjects. All patients (6/35) who died had greater than 2 co morbid illness.  
TABLE XIII 
 SURVIVORS  DECEASED 
>2  
COMORBID 
ILLNESS(n=18) 
12 6 
< 2 COMORBID 
ILLNESS  (n=17) 17 0 P VALUE .0303 
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ETIOLOGY 
Though the initial description of disease was of idiopathic nature the 
immediate etiological agent was found in about 70% of cases in most series. 
Eke et al reported that about 36% of cases had no source of infection to 
precipitate the disease process. 
In our study 34.3% of cases had no recognizable source of infection. In 
literature the colorectal source was the most common source of infection and 
in our study it was 42.8%. 
Unalp and Kim Yong et al proved that colorectal source of infection had 
increased mortality rate than other sources of sepsis. In our study 50 %( 3/6) of 
non survivors had colorectal source of infection. Since majority of the disease 
was due to colorectal etiological causes there is probability that it is 
increasingly associated with mortality. Also the infection from urogenital 
region is initially limited by perineal membrane but the perianal infection and 
gangrene easily spreads to anterior abdominal wall. 
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DURATION OF SYMPTOMS 
The range of duration of symptoms of was from 2 to 7 days. Yeniyol et 
al found that duration of symptoms was a significant factor affecting mortality. 
None of the patients who presented before 48 hours had death as outcome. 
Unalp et al ,Yeniyol et al , Kim et al and Akgun et al found that duration of 
symptoms  >3 days was associated with increased mortality. In the study we 
found that the mean of all patients with mortality was found to be 4.58 and this 
increased duration was found to be statistically significant. 
Variable MORTALITY N Mean Std. Dev P-Value 
DURATION OF  
SYMPTOMS 
(DAYS) 
No 29 2.66 0.877 
<0.001 
Yes 6 4.5 0.801 
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Fournier’s gangrene severity index 
When first introduced in 1995 by Laor et al he found that the mean score 
of all non survivors was found to be 13.5. Subsequently in studies conducted 
by Yeniyol,Ulu,Cyzmet,Erol,Lujan(49) the results are given below. 
TABLE XIV 
 
In most of the studies the ROC curve was plotted and the best probable 
score for predicting the mortality was found out. In all studies quoted above, 
FGSI score greater 9 was highly predictive of mortality 
In our study the mean age of deceased was 14.5.  Using ROC plot curve 
the best cut off score for mortality was found to be 11. The higher mean score 
in our patients was due to the delayed presentation after systemic sepsis has set 
in. 
108 
 
The sensitivity and specificity of the score 11 to predict the non survival 
status was 100%.   
A FGSI Score greater than 9 was defined to have higher mortality. In 
our study we had 3 patients with score greater than 9 (9, 10 &10) who had 
survived. This highlights the importance of more aggressive management in 
this group of patients which offers them a survival benefit. In our study, 
patients with score  greater than 9 had an average of 3 debridement to control 
the spread of gangrene and infective process. This debridement was done 
under anesthesia besides the regular dressing and debridement in wards.  
Chawla(50) in 2003 suggested in his study that no. of debridements were 
found significantly higher in survivors. This was explained by the fact that 
sicker patient who had survived the initial attack would require multiple 
debridements to limit the disease process .  
Ersay et al(51) noted that subjects with higher FGSI score had increased 
no. of debridement and increased duration of hospital stay. In other study by 
Cemal Goktas(52)  FGSI score was made before each debridement. He found 
that a higher score before each debridement predicted the possibility of 
multiple debridements at a future date. This was explained by the fact that 
cases where the score was increasing the disease and septicemia was also 
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progressing. So they required further debridements to control the disease 
process. To conclude the FGSI score also predicts the morbidity in survived 
patients. They require multiple debridements and possibly a diverting 
procedure to limit the contamination.     
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CONCLUSIONS 
Fournier gangrene is a notorious surgical emergency which requires 
early diagnosis and treatment.  
Minor infection in predisposed individuals should be given due attention 
and treated promptly as negligence may lead to this life threatening 
complication. Proper education should given to these individuals regarding 
warning symptoms and they should be advised to seek medical help if any 
signs appear. 
Once diagnosed, early stabilization of hemodynamic status and 
immediate debridement of whole necrotic tissues with appropriate antibiotic 
cover will certainly reduce the risk of morbidity. 
Presence of  Diabetes, advanced age, primary colorectal source of 
infection, delayed presentation above 48 hours , systemic sepsis on admission 
are individual risk factors described to predict the mortality. 
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FGSI score is a simple score based on vital parameters and basic lab 
investigations. 
A  FGSI score greater than 9 should alert the surgeon to carry out 
immediate and extensive surgical debridement. This offers these patients a sure 
survival benefit.  
A score greater than nine also predicts the morbidity. Patients with score 
greater than 9 who survived will probably have extensive area of involvement. 
They will need multiple surgical debridements and diversion procedure to 
hasten wound healing. 
Hence it is very useful and simple test which can be easily reproduced 
and aids in both prediction of mortality and morbidity. 
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        PROFORMA 
OBSERVATIONAL STUDY OF FOURNIER’S GANGRENE AND   
USEFULNESS OF FOURNIER’S GANGRENE SEVERITY INDEX  IN 
PREDICTING THE OUTCOME  
PATIENT DATA: 
PATIENT NAME    :      AGE/SEX: 
Hospital Number      : 
Date of admission    : 
Date of surgery        : 
Date of discharge     : 
 
History of illness : 
i. Presenting complaints: 
 
ii. Disease onset  
iii. Duration of symptoms  
iv. Progress of symptoms  
Predisposing  factors: 
i. Diabetes 
ii. Alcoholism 
iii. Malignancy 
iv. Immune compromised state 
v. Morbid obesity 
vi. Low socioeconomic status 
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Causative factor: 
• Anorectal 
• Urogenital  
• Cutaneous 
• Idiopathic 
 
Patient examination: 
Vital parameters : 
Parameter  Patient’s value  Score allotted  
Heart rate 
 
  
Respiratory rate  
 
  
Temperature  
 
  
 
Blood investigations: 
Parameter  Patient’s value  Score allotted  
Hematocrit    
Leukocyte count   
Creatinine    
Serum sodium   
Serum potassium   
Serum bicarbonate   
 
 
FOURNIER GANGRENE SEVERITY INDEX SCORE: 
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Extent of the disease: 
 
Wound culture and sensitivity: 
 
Details of debridement and other surgeries: 
 
 
 
 
Reconstruction procedure used: 
 
 
Total duration of hospital stay     : 
 
Number of surgeries performed  : 
 
Follow up : 
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OBSERVATIONAL  STUDY OF  FOURNIER’S GANGRENE AND USEFULNESS OF 
FOURNIER’S GANGRENE SEVERITY INDEX IN PREDICTING THE OUTCOME 
Investigator: Dr. P .NAVEEN, II yr Post Graduate MS (Gen Sur) 
Guide: Prof. Dr. A.  RAJENDRAN, Chief,  Surgical  Unit  6,  Govt.  Stanley 
Hospital. 
________________________________________________________________________________
_____ 
Informed Consent 
Name:       Age/ Sex:  IP: 
I herewith declare that I have been explained in a language fully understood by me 
regarding the purpose of this study, methodology, details and data collected for this study. 
I have been given an opportunity to discuss my doubts and I have received the appropriate 
explanation. 
I understand that my participation in this study is completely voluntary and that I am free to 
withdraw from this study at anytime without any prior notice &/ or without having my 
medical or legal rights affected. 
I permit the author and the research team full access to all my records at any point, even if I 
have withdrawn from the study. However my identity will not be revealed to any third party 
or publication. 
I, being a person of sound mind, hereby give my permission to use a photograph(s) of me 
taken intra operatively in the dissertation. 
I herewith permit the author and the research team to use the results and conclusions arising 
from this study for any academic purpose, including but not limited to dissertation/ thesis or 
publication or presentation in any level. 
Therefore, in my full conscience, I give consent to be included in the study and to undergo 
any investigation therein. 
 
Patient’s Sign       Investigator’s Sign 
When completed, 1 for patient, 1 for researcher site file, 1 (original) to be kept in medical notes    
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OBSERVATIONAL STUDY OF FOURNIER’S GANGRENE AND 
USEFULNESS OF FOURNIER’S GANGRENE SEVERITY INDEX IN 
PREDICTING THE OUTCOME 
Investigator: Dr. P .NAVEEN, II yr Post Graduate MS (Gen Sur) 
Guide: Prof. Dr. A. RAJENDRAN, Chief, Surgical Unit 6, Govt. Stanley 
Hospital.    
 
 
PATIENT INFORMATION MODULE 
 
 
Invitation to Participate: 
You are being invited to participate in this study.  Since you have been 
diagnosed to have Fournier’s gangrene you are being invited to participate in 
this study. You have the right to know that consent is purely voluntary, that 
your permission to participate in research may be withdrawn at any time, and 
that you may discontinue participation in all or part of the research without 
affecting your present or future medical care. Please take your time to review 
this form.  Feel free to discuss it with your family before you make your 
decision.  
 
What is Fournier’s gangrene and what is the nature and course of the 
disease? 
 
Fournier’s gangrene is a necrotizing soft tissue infection involving the scrotum 
and perineal area. This gangrene involves the skin and subcutaneous tissues 
initially. If these gangrenous and infected areas are not surgically removed 
immediately it will lead to rapid spread to abdominal wall and chest wall and 
death due to sepsis and multi organ failure. 
 
Why is This Study being done and aim of the study? 
 
This study analyses the age distribution, predisposing factors and risk factors 
of patients diagnosed with Fournier‘s gangrene. 
The study observes the need for surgical debridement and other procedures in 
management of Fournier’s gangrene  
To assess the usefulness of an index called Fournier’s gangrene severity index 
which uses simple parameters to predict the mortality rate. 
. 
 
How Many People Will Take Part in the Study? 
127 
 
About 30 patients are expected to take part in this study. All patients diagnosed 
with Fournier’s gangrene between the ages 20-80 will be included in the study. 
  
 
 
 
 
What are the details obtained from the patient and investigation done in 
this Study? 
 
If you agree to participate in this study, patient or relatives will be asked to 
sign the consent form.  
This study is primarily done to assess the patient’s disease severity and 
mortality rate. Once the patient is diagnosed as a case of Fournier’s gangrene 
and admitted to emergency ward of Govt. Stanley hospital the patient’s history, 
predisposing factors and risk factors are noted down. 
 Patient’s heart rate respiratory rate and body temperature are noted down. 
Later the routine blood investigations are done. The Fournier’s severity index 
score is calculated based on the above parameters. 
 
Does the modality of treatment received by the patient change in this 
study? 
 
This study observes the predisposing factors, risk factors and predicts the 
mortality using the Fournier severity index score. In this study the treatment 
modality of immediate surgical debridement and further wound care remains 
the same and no new form of treatment is being instituted. There will be no 
delay in the initiation or progress of treatment due to the study.   
 
What Are the Risks of the Study? 
 
 There are virtually no risks involved in the study. The vital parameters and 
blood investigations of the patients are used. When blood is requested, a 
trained technician, nurse or doctor will obtain the blood samples.  
Complications that may arise as a result of blood collection are typically 
minimal and may include bruising and swelling. 
 
The mode of treatment, principles of surgery, dressings and wound care of 
patients with Fournier’s gangrene are adhered to standard protocols and no 
modifications are done to these. Since it’s an observational study the natural 
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course of disease and hospital data regarding surgery, wound care and final 
outcome of the patients are observed, noted and stastically analysed. 
 
There will not be any monetary benefits for participating in this study. 
 
Are There Alternatives to the Study? 
You have the alternative of not participating in this study.  Your participation 
is completely voluntary and will not affect your medical treatment now or in 
the future. 
 
  All information collected in this study will be kept strictly confidential. 
The information regarding the disease and lab details obtained from the patient 
in this study will be used for statistical analysis and research purposes. The 
patient’s age, sex and other personal information will not be revealed. The data 
collected and the Fournier gangrene severity index score will be used to predict 
the outcome and results will be stastically analysed.  
 
 
 
 
 
Investigator’s Sign       Patient’s Sign 
              Name of the patient  
 
 
 
Date : 
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MASTER CHART 
 
  
 
 
 
 
 
 
NAME  AGE  SEX  IP NO.
PRE 
DISPOSING 
FACTORS
ETIOLOG
Y
DURATION 
OF 
SYMPTOM
S(DAYS)
TEMP HEART RATE RR
HEAMTOC
RIT
TOTAL 
COUNT
CREATIN
INE SODIUM
POTASSI
UM
BICARBONAT
E
FGSI 
SCORE
NO. OF 
DEBRIDE
ME-NTS
RENAL 
FAILURE
MORTA
LIITY
MOHAN 62 M 2319 DM CR 3.5 38.5 98 20 42 9000 1.9 138 3.9 22 2 1 YES NO
RAJAN 62 M 2923 DM/Ch.A CR 4 39 118 36 40 16,000 3.2 127 2.8 26 12 2 YES YES
ELLAPAN  50 M 598 DM CR 3.5 38.6 104 26 42 11,000 1.7 139 3.6 24 3 1 YES NO
VENKATESAN 74 432 DM/A CR 4 38.4 98 20 44 10500 2.1 139 4.1 28 3 1 YES NO
PERUMAL 51 M 1278 DM/A UG 2 39.12 112 22 46 3800 1.8 126 5.2 31 8 1 NO NO
KRISHNAN 48 M 2034 NONE CR 2 39.1 112 29 36 12000 1.2 132 3.6 29 6 1 NO NO
KRISHNA MOORTHY
53 M 2343 CKD UG 3 38.6 114 30 48 11200 2.7 138 5.1 20 7 1 YES NO
RAMASAMY 78 M 2654 DM/Ch.A/CKD CR 5 39.2 114 28 32 13,500 3.8 129 5.2 32 16 1 YES YES
KRISHNAMOORTHY 68 M 2964 DM/HF/Ch.A CR 4.5 39.2 128 26 36 20,500 3.8 128 3.2 28 19 1 YES YES
RAMAPOORANAM 51 M 2835 DM CR 2 38.6 96 26 42 13600 1.2 138 3.9 26 2 2 YES NO
RAMAKRISHNAN 71 M 3245 DM/HF CUT 3 38.3 106 22 38 10800 1.3 129 4.5 28 1 2 YES NO
KUMAR 68 M 4309 DM ID 2 38.4 108 24 39 8600 1.6 136 4.2 30 2 1 YES NO
MURUGAN 41 M 6432 DM/Ch.A/HIV UG 2.5 37.1 96 23 43 43 7600 136 3.8 23 0 1 NO NO
KAMALESHWARAN 66 M 7493 DM/Ch.A CUT 4.5 39.1 112 26 44 14000 1.6 138 4.1 21 10 3 YES NO
PALANI 53 M 8634 DM/Ch.A ID 2 37.6 106 35 48 12000 1.2 141 4.3 26 1 2 YES NO
DASAN 52 M 12321 DM/Ch.A CR 2 38 112 26 44 13800 1.4 141 3.9 20 3 2 YES NO
SUMATHI 46 F 12654 DM ID 2 37.6 102 36 48 7900 1.1 139 3 29 2 2 YES NO
JOSEPH 66 M 13421 DM ID 4 37.6 98 26 48 1400 1.4 133 4.1 26 2 1 YES NO
SALEEM 40 M 18345 HIV CUT 3 39.1 108 26 44 2800 1.7 128 4.1 23 10 4 NO NO
CHINNAYIAN 49 M 20346 DM/Ch.A ID 1 39.1 102 21 42 12,000 0.8 137 3.2 22 4 2 NO NO
MOTIYAN 64 M 23674 DM/Ch.A/CKD ID 4 38.6 98 26 46 16000 3.2 128 5 19 11 1 YES YES
JABBAR ALI 47 M 27432 DM/Ch.A ID 2 38 102 28 40 12500 1.2 139 4.8 18 3 1 NO NO
ISSAC 54 M 29321 DM/Ch.A ID 3 38.6 108 26 42 13000 1.9 142 4.1 24 4 1 YES NO
PARANTHAMAN 41 M 32120 NONE CR 2.5 38.7 118 22 39 13500 1.4 137 4.2 28 3 1 NO NO
SENGUTUVAN 54 M 33400 DM CR 2 37.9 98 24 42 10,500 1.9 139 4.2 29 2 1 YES NO
PURUSHOTHAMAN 48 M 35432 DM ID 2 37.8 100 28 40 9000 1.2 128 4.1 18 4 1 NO NO
KANNAN 76 M 37823 DM/HF CR 4 39.2 108 30 44 8000 1.9 128 4.9 19 10 3 YES NO
PARTHIBAN 61 M 40193 CA/Ch.A CUT 6 39.1 114 26 46 16,500 2.2 125 4.1 21 13 1 YES YES
KRISHNAN 59 M 42156 DM ID 2.5 37.2 118 26 42 10800 1.9 136 4.8 19 4 2 YES NO
SADIYANDI 55 M 47321 DM ID 2.5 37.9 98 22 39 9800 1.6 139 3.9 18 2 1 YES NO
SRIKANTH 62 M 49354 DM CR 4 37.8 98 24 44 10200 1.8 141 3.8 23 2 1 YES NO
RAJENDRAN 58 M 53219 DM CR 3 37.6 96 22 48 9900 1.9 138 4.8 19 4 2 YES NO
JAMES VICTOR 47 M 56783 DM/Ch.A ID 2 37.2 98 28 48 10800 1.2 139 4.9 23 2 1 NO NO
MITHLESH 44 M DM CR 1.5 38.2 110 24 43 9800 1.3 138 3.8 25 2 1 NO NO
VENKATESHWARAN
62 M 58732 DM/Ch.A/CKD UG 4 38.6 112 20 48.2 16,300 3.2 128 3 20 13 1 YES YES
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MOHAN 62 M 2319 DM CR 3.5 38.5 98 20 42 9000 1.9 138 3.9 22 2 1 YES NO
RAJAN 62 M 2923 DM/Ch.A CR 4 39 118 36 40 16,000 3.2 127 2.8 26 12 2 YES YES
ELLAPAN  50 M 598 DM CR 3.5 38.6 104 26 42 11,000 1.7 139 3.6 24 3 1 YES NO
VENKATESAN 74 432 DM/A CR 4 38.4 98 20 44 10500 2.1 139 4.1 28 3 1 YES NO
PERUMAL 51 M 1278 DM/A UG 2 39.12 112 22 46 3800 1.8 126 5.2 31 8 1 NO NO
KRISHNAN 48 M 2034 NONE CR 2 39.1 112 29 36 12000 1.2 132 3.6 29 6 1 NO NO
KRISHNA MOORTHY
53 M 2343 CKD UG 3 38.6 114 30 48 11200 2.7 138 5.1 20 7 1 YES NO
RAMASAMY 78 M 2654 DM/Ch.A/CKD CR 5 39.2 114 28 32 13,500 3.8 129 5.2 32 16 1 YES YES
KRISHNAMOORTHY 68 M 2964 DM/HF/Ch.A CR 4.5 39.2 128 26 36 20,500 3.8 128 3.2 28 19 1 YES YES
RAMAPOORANAM 51 M 2835 DM CR 2 38.6 96 26 42 13600 1.2 138 3.9 26 2 2 YES NO
RAMAKRISHNAN 71 M 3245 DM/HF CUT 3 38.3 106 22 38 10800 1.3 129 4.5 28 1 2 YES NO
KUMAR 68 M 4309 DM ID 2 38.4 108 24 39 8600 1.6 136 4.2 30 2 1 YES NO
MURUGAN 41 M 6432 DM/Ch.A/HIV UG 2.5 37.1 96 23 43 43 7600 136 3.8 23 0 1 NO NO
KAMALESHWARAN 66 M 7493 DM/Ch.A CUT 4.5 39.1 112 26 44 14000 1.6 138 4.1 21 10 3 YES NO
PALANI 53 M 8634 DM/Ch.A ID 2 37.6 106 35 48 12000 1.2 141 4.3 26 1 2 YES NO
DASAN 52 M 12321 DM/Ch.A CR 2 38 112 26 44 13800 1.4 141 3.9 20 3 2 YES NO
SUMATHI 46 F 12654 DM ID 2 37.6 102 36 48 7900 1.1 139 3 29 2 2 YES NO
JOSEPH 66 M 13421 DM ID 4 37.6 98 26 48 1400 1.4 133 4.1 26 2 1 YES NO
SALEEM 40 M 18345 HIV CUT 3 39.1 108 26 44 2800 1.7 128 4.1 23 10 4 NO NO
CHINNAYIAN 49 M 20346 DM/Ch.A ID 1 39.1 102 21 42 12,000 0.8 137 3.2 22 4 2 NO NO
MOTIYAN 64 M 23674 DM/Ch.A/CKD ID 4 38.6 98 26 46 16000 3.2 128 5 19 11 1 YES YES
JABBAR ALI 47 M 27432 DM/Ch.A ID 2 38 102 28 40 12500 1.2 139 4.8 18 3 1 NO NO
ISSAC 54 M 29321 DM/Ch.A ID 3 38.6 108 26 42 13000 1.9 142 4.1 24 4 1 YES NO
PARANTHAMAN 41 M 32120 NONE CR 2.5 38.7 118 22 39 13500 1.4 137 4.2 28 3 1 NO NO
SENGUTUVAN 54 M 33400 DM CR 2 37.9 98 24 42 10,500 1.9 139 4.2 29 2 1 YES NO
PURUSHOTHAMAN 48 M 35432 DM ID 2 37.8 100 28 40 9000 1.2 128 4.1 18 4 1 NO NO
KANNAN 76 M 37823 DM/HF CR 4 39.2 108 30 44 8000 1.9 128 4.9 19 10 3 YES NO
PARTHIBAN 61 M 40193 CA/Ch.A CUT 6 39.1 114 26 46 16,500 2.2 125 4.1 21 13 1 YES YES
KRISHNAN 59 M 42156 DM ID 2.5 37.2 118 26 42 10800 1.9 136 4.8 19 4 2 YES NO
SADIYANDI 55 M 47321 DM ID 2.5 37.9 98 22 39 9800 1.6 139 3.9 18 2 1 YES NO
SRIKANTH 62 M 49354 DM CR 4 37.8 98 24 44 10200 1.8 141 3.8 23 2 1 YES NO
RAJENDRAN 58 M 53219 DM CR 3 37.6 96 22 48 9900 1.9 138 4.8 19 4 2 YES NO
JAMES VICTOR 47 M 56783 DM/Ch.A ID 2 37.2 98 28 48 10800 1.2 139 4.9 23 2 1 NO NO
MITHLESH 44 M DM CR 1.5 38.2 110 24 43 9800 1.3 138 3.8 25 2 1 NO NO
VENKATESHWARAN
62 M 58732 DM/Ch.A/CKD UG 4 38.6 112 20 48.2 16,300 3.2 128 3 20 13 1 YES YES
